The Impact of Obesity on Mortality and Complications in Posterior Retroperitoneoscopic Adrenalectomy
Cureus · 25.07.2023
DOI: 10.7759/cureus.42421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 25.07.2023. Verfasst von Yi Th'ng Seow und 5 weiteren Autor:innen. Beteiligte Einrichtung: General and Endocrine Surgery, Royal Perth Hospital, Perth, AUS. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Obesity is a global epidemic. It influences surgical technique, ergonomics, safety, and outcomes. However, there is a paucity of evidence of obesity-related impact in posterior retroperitoneoscopic adrenalectomy (PRA). This study compared perioperative outcomes of obese and non-obese participants undergoing PRA. Methodology This is a multi-center retrospective cohort study of elective PRA from March 2014 to December 2022. Patient demographics, surgical techniques, clinicopathological parameters, and outcomes, including overall complication rate, were analyzed using SPSS version 27 (IBM Corp., Armonk, NY, USA).
Results
Seventy-five patients underwent a PRA, of which 97.3% were completed retroperitoneoscopically. The overall complication rate was (9.3%), and on subgroup analysis, the obese cohort had a lower percentage complication profile at 6.5%. Male participants comprised 52%, with a median age of 55 (IQR=19). The median BMI was 29.0 (IQR=8), of which 41% were obese, and 40% were overweight. Univariate analysis showed that being obese was not significantly associated with a higher complication rate (p=0.471). In addition, there was no significant increase in conversion (p=0.508), bleeding/transfusion (p=0.508), surgical site infection (SSI; p=1.000), incisional hernia (p=1.000), ICU or high dependency unit admission (p=0.292) and any-cause mortality (p=1.000). No sentinel deaths directly related to PRA were recorded. Procedure duration was longer in obese (117 mins) vs. non-obese participants (88.9 mins, p=0.022). However, there was no significant difference in the length-of-hospital stay (p=0.592). The cohort conversion rate was (2.7%), and tumor size was associated with a higher conversion rate (35.4 vs. 62.5mm, p=0.040).
Conclusion
Posterior retroperitoneoscopic adrenalectomy can be a safe procedure in obese populations, and obesity does not increase perioperative morbidity or mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General and Endocrine Surgery, Royal Perth Hospital, Perth, AUS.
- General Surgery, Fiona Stanley Hospital, Perth, AUS.
- General and Endocrine Surgery, St. John of God Murdoch Hospital, Murdoch, AUS.
Zitieren
APA
Seow, Y. T., Nyandoro, M. G., Poh, S., Tee, Y. C., Yew, M. K., & Wong, S. L. (2023). The Impact of Obesity on Mortality and Complications in Posterior Retroperitoneoscopic Adrenalectomy. Cureus. https://doi.org/10.7759/cureus.42421
Vancouver
Seow YT, Nyandoro MG, Poh S, Tee YC, Yew MK, Wong SL. The Impact of Obesity on Mortality and Complications in Posterior Retroperitoneoscopic Adrenalectomy. Cureus. 2023. doi:10.7759/cureus.42421
BibTeX
@article{Seow2023,
author = {Seow, Yi Th'ng and Nyandoro, Munyaradzi G and Poh, Shearn and Tee, Yeow Chun and Yew, Ming Khoon and Wong, Sze Ling},
title = {The Impact of Obesity on Mortality and Complications in Posterior Retroperitoneoscopic Adrenalectomy},
journal = {Cureus},
year = {2023},
doi = {10.7759/cureus.42421}
}
EUVIMED